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Introduction 
 
The concept of risk factors has evolved only over the past 45 
years. Since the early 1960s and particularly following the 
Framingham study in the late 1970s, many factors that predispose to 
the development of atherosclerosis and cardiovascular disease (CVD) 
have been thoroughly investigated (1). 
The list of these factors, now called cardiovascular risk factors (CRFs), 
continues to grow and new factors are periodically added to the list as 
our comprehension of the disease process grows. Extensive clinical 
and statistical studies have identified several factors that increase the 
risk of CVD (2, 3, 4, 5). 
Major risk factors are those that research has shown significantly 
increase the risk of heart and blood vessel disease (3). 
Some CRFs can't be modified as advanced age, male gender, heredity 
(including race, family history of CVD), and some can be modified, 
treated or controlled as smoking, dyslipidemia,  hypertension, diabetes 
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mellitus,  physical inactivity, overweight and obesity (especially 
abdominal obesity). Nowadays other new modifiable CRFs, as alcohol, 
fruit and vegetables consumption and stress, has been identified. The 
significance and prevalence of these, called contributing risk factors, 
have not yet been precisely determined.  
Several of these risk factors are interrelated. Obesity, cigarette 
smoking and lack of exercise adversely influence blood pressure and 
blood cholesterol levels (6). The greater the level of each risk factor, 
the greater the risk, and the more risk factors a person has, the greater 
the likelihood of developing cardiovascular disease (7). 
CVD result in substantial disability and loss of productivity and 
contribute in large part, to the escalating costs of health care, 
especially in the presence of an ageing population. CVDs are the major 
cause of death in adults and elderly in the majority of the developed 
countries and in many developing countries. Papers published by the 
World Health Organization of the United Nations (WHO) and others 
(8, 9, 10, 11) have previously reported trends in cardiovascular 
mortality over time (12). 
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These reports showed large international between-country differences 
both in the levels and in the trends in mortality from CVDs with a 
substantial increase in countries of Central and Eastern Europe 
concomitant with recent nutritional, economical and political changes 
(13, 14). 
Sans et
 
al.(12) reported a clear north–east to south–west gradient in 
CVD mortality (1990–1992; 45–74 years age-adjusted) with the lowest 
rates for both men and women
 
in France, Spain, Switzerland, and Italy 
(12). Regional variations in cardiovascular mortality have been 
observed
 
both between and within countries in Europe (11, 12, 15, 16). 
There are many reasons for the observed regional variations. They 
include differences between
 
populations in ―classic‖ CRFs as well as 
socio-economic factors and lifestyle variables. These large differences 
have been also mainly attributed to environmental factors and in 
particular to differences in dietary pattern, especially in favour of 
Mediterranean countries where low rates of cardiovascular- and 
cancer-related mortality have been reported (17). The current 
European
 
Guidelines on Cardiovascular Disease Prevention in Clinical
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Practice take national variation in cardiovascular mortality
 
into account 
(18).  
The improvement of some CRFs seems to be the main reason for the 
decrease in cardiovascular morbidity and mortality in Italy and in most 
Western countries over the last decades (19, 20, 21, 22, 23, 24, 25). 
This is partly due to an early management of CRFs by lifestyle 
modifications and/or pharmacological intervention with a reduction in 
their level (26, 27, 28, 29). 
An inverse trend can be observed for obesity, whose prevalence is 
steadily increasing (30, 31, 32, 33). Scientific evidence accumulated 
over recent years has prompted the American Heart Association to 
identify obesity as the major and modifiable risk factor for CVDs, and 
the UK Government (Department of Health) to include obesity as one 
of the six key priorities in the White Paper Choosing Health: Making 
Healthy Choices Easier and the Italian Ministry of Health to launch 
the Project 'Guadagnare Salute' which foresees multidisciplinary 
interventions in the field of diet and physical activity (2, 34, 35).  
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In 2005 the French agency for research and information on fresh fruits 
and vegetables (Aprifel), the Italian Ministry of Health and the 
National Centre for Disease Prevention and Control (CCM), organized 
the International Conference on Health Benefits of Mediterranean 
Style Diet - From Scientific Evidence to Health Prevention Actions - 
with the aim of highlighting the latest scientific knowledge on health 
benefits of Mediterranean style diet and the strategic perspectives for 
health operators (36, 37, 38, 39). 
In Italy, latest available data on overweight and obesity come from the 
multi-scopes surveys performed in 2003 and published in 2005, and 
more recently performed in 2005 and published in 2007 by the Italian 
Institute of National Statistics (ISTAT), collecting self-reported 
information on health status (40, 41) and from the Epidemiologic 
Cardiovascular Observatory (OEC) of the Progetto CUORE, 
estimating prevalence of overweight, obesity and other CVD risk 
factors in Italian men and women aged 35–74 years examined between 
1998 and 2002 (42).  
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More recently, 2090 Italian men and women aged 35–74 years were 
screened by general practitioners to assess their cardiovascular risk, 
lifestyles habits and drug use (43). 
Therefore, there is a pressing need to update and collect reliable and 
comparable data focusing on more recent CRFs to establish a national 
surveillance and prevention program. 
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Aim 
 
Aims of this cross-sectional study were to assess the prevalence 
of CRFs; to describe the alcohol, fruit and vegetables consumption; to 
investigate the family history of diabetes, hypertension, dyslipidemia 
and obesity; to evaluate the association between obesity/overweight or 
high waist circumference and some CRFs, in a large cohort of Italian 
men and women aged over 18 years, in five Italian macroareas. 
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Materials and Methods 
 
Screening 
The study was performed in 24.609 Italian individuals (men and 
women), aged over 18 years (mean age of the study population 
56.915.3 years). The individuals were participants in an information 
program for the prevention of the metabolic syndrome ―Misuriamoci‖, 
conducted by the Croce Rossa Italiana (CRI) on the 24
th
 and 25
th
 of 
March 2007 in collaboration with the Italian Association of General 
Practitioners (SIMG) and “la Federazione nazionale dei titolari di 
farmacia italiani” (FEDERFARMA) and supported by the Italian 
Ministry of Health. 
Advertising was conducted by radio and television announcements, 
spot on ATAC buses and adverts in the pharmacy, supported by 
Takeda Italia Farmaceutici, Multicare, FederFARMACO and Pacini 
editore. 
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The study involved people who spontaneously went to the main 
squares of 193 Italian cities. A paper questionnaire was developed by 
Nutrition section of Neuroscience Dpt. of University of Naples 
―Federico II‖. Subjects were asked about their personal data, habits 
(smoking, physical activity, alcohol consumption, fruit and vegetable 
consumption), family history of diabetes, hypertension, dyslipidemia 
and/or obesity, current drug treatments (anti-hypertensive, lipid-
lowering, anti-diabetic). Anthropometric (weight, height and waist 
circumference) and blood pressure measurements were performed 
using standardized methodologies (standard electronic scale, wall 
height ruler, tape measure at the level of the umbilicus and mercury 
sphygmomanometer). Total cholesterol,  tryglicerides and blood 
glucose were assessed in all subjects.  
 
Data analysis 
Body mass index (BMI) was calculated as weight (kg) divided 
by height squared (m
2
). The distribution of overweight and obesity was 
 11 
calculated considering the following categories: overweight as BMI 
25.0-29.9 kg/m
2
 and obesity as BMI ≥30 kg/m2. 
Fasting cholesterol, triglycerides and glucose level were collected by 
finger-prick capillary blood samples using Multicare® diagnostic 
device (44). 
According to the NCEP ATP III criteria (45), abdominal obesity was 
defined as waist
 
circumference ≥102 cm in men and ≥88 cm in 
women. Blood pressure was recorded as the average of two 
measurements after subjects had been sitting for 5 min. The average of 
the two readings was used in the analysis. Elevated
 
blood pressure 
level was considered if having systolic blood pressure ≥ 130 mmHg 
and/or diastolic blood pressure ≥ 85 mmHg or if they reported taking 
antihypertensive medication. Hyper-trygliceridemia was considered 
with serum triglycerides level ≥ 150 mg/dl or if they reported taking 
anti-dyslipidemic medication (45). Impaired fasting glucose 
(Hyperglycemia) was defined as a fasting plasma glucose level in the 
range of 100 mg/dl up to 125.9 mg/dl and diabetes was considered as 
fasting blood glucose ≥126 mg/dl or if they reported taking anti-
 12 
diabetic medication (46). High blood total cholesterol was defined as ≥ 
200 mg/dl or if they reported taking anti-dyslipidemic medication (47). 
For alcohol intake and fruit and vegetable consumption 
(fruit&vegetable) a commonly used serving size was specified and 
subjects were asked ―if and how often they had consumed that unit‖. 
Daily and/ or weekly consumption was asked for fruit&vegetable. An 
average consumption of 3-5 servings-a-day of fruit and vegetables was 
considered as recommended (48,49, 50,51).  
Alcohol intake was recorded as glasses per week (one glass is defined 
as 4 fl oz of wine). An average daily intake of 1 glass for men and of ½ 
glass for women was considered as recommended (52). 
About the geographic distribution Italy was considered as a whole and 
the following macroareas (i.e. area comprising more Regions, 
generally contiguous): Northwest, including data from Valle d’Aosta, 
Piemonte, Liguria and Lombardia; Northeast, including data from 
Trentino-Alto Adige, Friuli-Venezia Giulia, Veneto and Emilia 
Romagna; Center, including data from Toscana, Marche, Umbria and 
Lazio; South including data from Campania, Abruzzo, Molise, 
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Calabria, Puglia and Basilicata; and Islands including data from 
Sicilia and Sardegna. 
Data are expressed as mean  SD or frequencies to present continuous 
or categorical variables. Separate prevalence results are presented for 
men and women. Qualitative and quantitative variables were compared 
with parametric and non parametric tests, as appropriate. Logistic 
regression models were used to estimate the independent relationship 
between obesity/overweight or high waist circumference and CRF. 
Potential confounders that were chosen before the analysis included 
gender, macroarea, fruit&vegetables and alcohol intake. In the 
multivariate model for obesity/overweigh the high waist circumference 
was added to the covariates as a confounder and viceversa. Analysis 
were performed using STATA 9.2 SE (Stata Corp., College Station, 
TX). 
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Results 
 
The study population aged 18-98 years, is normally distributed 
as confirmed by the values of the mean (5715 years) and the median 
(59 years). The distribution of the examined population among the 
macroareas and between gender is representative of the Italian 
population (53). 
The main demographic, clinical and metabolic characteristics of 
the study population according to gender and macroarea are shown in 
table 1. The mean BMI is 26.9±4.4 with men showing a higher mean 
than women (27.5±3.9 vs 26.2±4.9). Mean waist circumference value 
of women exceeded the gender-specific cut-off (women:91±13; 
men:101±11). The average of systolic blood pressure value is high 
(134±19) and men are affected more than women (136±18 vs 132±19). 
Plasma triglycerides mean level also is high (153±81) and women 
show higher levels than men (158±84 vs 149±78). 
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Table 2 shows the prevalence of some CRFs in the study 
population according to gender and macroarea. 22% of the population 
is identified as obese and 41% as overweight. The prevalence of 
obesity and overweight is different in each macroarea. In particular, 
the highest prevalence of obesity (27%) is shown by South population, 
while the lowest one (16%) is shown by North-east population; 
moreover, the highest prevalence of overweight (44%) is shown by 
Islands population, while the lowest one (40%) is shown by North-
west population. Men are affected more than women both in the study 
population and in each macroarea. 
According to waist circumference cut off, the prevalence of abdominal 
obesity is 56% in the study population; South population shows the 
highest prevalence (59%), while North-east population shows the 
lowest one (52%). Women are affected more than men.  
In the study population the prevalence of smoking is 19%; Islands 
population shows the highest prevalence (24%), while North-west 
population shows the lowest one (15%). Men smoke more than 
women.  
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The total prevalence of hypertension is 73%; both North-west and 
North-east population show the highest prevalence (76%), while 
Islands population shows the lowest one (67%). Men are affected more 
than women. 
In the study population the prevalence of hypertriglyceridemia and 
hypercholesterolemia is 42% and 36% respectively. A higher 
prevalence of hypertrigliceridemia and hypercholesterolemia is 
observed in North-west, North-east and Center population compared to 
South and Islands ones. Women are affected more than men.  
The prevalence of diabetes mellitus is 15% in all subjects; South and 
Islands population show a higher prevalence than North-west, North-
east and Center population. Men are affected more than women.  
The total prevalence of hyperglycemia is 13%, and the highest 
prevalence is shown by Center population (18%). Men are affected 
more than women.  
By comparing the dietary pattern with the nutritional guidelines 
established by the major scientific associations (48, 49, 50) in order to 
prevent the major chronic diseases, we have found that the study 
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population reports an alcohol consumption higher than the 
recommended range in the 23% of the study population with a similar 
prevalence between gender. In particular, North-west and North-east 
population show an almost doubled prevalence of people reporting an 
alcohol consumption higher than the recommended range compared to 
South and Islands population (Table 3). 
66% of the study population shows a fruit and vegetables consumption 
in the recommended range. Women adhere more than men to the 
nutritional norm for fruit&vegetable. Geographic distribution show 
that in North-west, North-east and Center population the prevalence of 
people showing a fruit and vegetable consumption in the 
recommended range is higher than South and Islands population 
(Table 3). 
According to family history of CRF 45% of the study population 
shows a family history of hypertension, 33% of diabetes, 26% 
dyslipidemia while only 17% shows a family history of obesity (Table 
4). Women show a higher prevalence of family history of CRFs than 
men. North-west population show the highest prevalence of family 
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history of hypertension, obesity and dyslipidemia, while the highest 
prevalence of family history of diabetes is found in Islands population. 
As overweight and obesity have reached epidemic proportions 
worldwide (54), and the metabolic consequences of obesity are well 
documented (55, 56, 57), we have examined the association between 
overweight/obesity and CRFs adjusted for high waist circumference, 
gender, macroarea, fruit&vegetable and alcohol intake. Diabetes, 
hypertriglyceridemia and hypertension are positively associated with 
overweight/obesity while a negative association is found between 
overweight/obesity and age, smoking and hypercholesterolemia (Table 
5). 
Table 6 shows the association with high waist circumference of 
CRFs adjusted for overweight/obesity, gender, macroarea, 
fruit&vegetable and alcohol intake. Age, diabetes, hypertension, 
hypertriglyceridemia show a positive association with high waist 
circumference. No association is found between high waist 
circumference and hypercholesterolemia and smoking. 
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Figure 1 shows  the distribution of subjects having one or more 
CRFs in the study population. The prevalence of subjects with three or 
four CRFs is quite high (19.6% and 20.7%, respectively) and the 
prevalence of subjects having between two and five CRFs is 72.0 %. 
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Discussion 
 
This study provides information about the prevalence and 
distribution of some CRFs in a representative adult Italian population, 
which includes 24.609 subjects aged 18-98 years. 
The incidence of obesity has increased dramatically in the last 
years and have become an epidemiological emergency (32, 42, 58). 
This is confirmed by our results that show a mean value of BMI (26.9 
Kg/m
2
 ±4.4) falling in the overweight category for both men 
(27.5±3.9) and women (26.2±4.9). By comparing our results with data 
from the ISTAT survey (41), the prevalence of obesity has 
considerably increased over the last few years (22% vs 9.8%) while 
the prevalence of overweight has only slightly increased (41% vs 34.2 
%). A possible explanation for the discrepancy in obesity prevalence, 
may be due to the self-report data used by ISTAT compared to the 
direct measurements used in our study. Studies based on self-reported 
and direct measurements show different results in the obesity 
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prevalence; in fact, obese subjects tend to overestimate their high and 
to underestimate their weight, leading to an underestimation of the 
obesity prevalence (59). On the other hand, comparing our data with 
previous studies (42, 43, 60) using direct measurements, almost the 
same prevalences of obesity and overweight are found. The prevalence 
of obesity is quite similar between men and women, while the 
prevalence of overweight is quite doubled in men than women 
according to previous reports (41, 43) (Table 2). A possible 
explanation could be that women, nowadays, pay great attention to 
weight control. According to ISTAT (41), South population shows the 
highest prevalence of obesity while a lower prevalence of overweight 
is found in the North-west population. 
By comparing our results with data from the Epidemiologic 
Cardiovascular Observatory (OEC) of the Progetto CUORE (42), we 
found an increase in the mean waist circumference value both in men 
(101cm vs 95cm) and women (91cm vs 85cm), and the prevalence of 
abdominal obesity, as exceeding gender specific waist circumference 
cut-off, is higher in women than in men (62% vs 51%) (43, 61) and in 
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South (59%) than in other macroareas. This agree with a positive trend 
of the waist circumference gradient observed over the last few years 
(62). 
Obesity and waist circumference result in various metabolic disorders 
that raise the risk of CVDs (63, 64). High triglyceride level has been 
observed in subjects with abdominal obesity (65), and 
hypertriglyceridemia is a well-known risk factor of CVDs (66, 67). 
Interestingly in our study the prevalence of hyper-triglyceridimia is 
almost doubled than in previous study (42). This could be the result of 
unhealthy eating habits and increased intake of fast foods and other 
high fat content food, in the Italian population over the last years.  
In the same way, the prevalence of diabetes and hyperglycemia are 
almost doubled compared to previous surveys (41, 42); while the 
prevalence of diabetes is similar when compared to a more recent 
study (43). These findings are important as they represent an alarming 
risk for CVDs. 
On the contrary, in our study the prevalence of hypercholesterolemia is 
lower than in previous survey (42), although it is similar when 
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compared with a more recent study (43). Therefore, over the last few 
years it seems to exist a positive trend in the prevalence of some 
metabolic parameters as hypertriglyceridemia, diabetes and 
hyperglycemia, and a negative trend in the prevalence of 
hypercholesterolemia. In addition, according to previous studies (42, 
61, 68), men show a higher prevalence of diabetes (17 % vs 12%) and 
hyperglycemia (14% vs 12%) than women; while women show a 
higher prevalence of hypercholesterolemia (42% vs 30%) and 
hypertriglyceridemia (45% vs 40%) than men (69). 
However, the most important finding is that hypertension is the main 
CRF in the study population (73%). Our data show a prevalence of 
hypertensive people much higher than ISTAT (12.9%; 13.6%) (40,41) 
and OEC (48.5%) (42) data. Possible explanations of this finding are 
that ISTAT survey considered a wide age range (0 – over 80 years), 
and used self-reported data that underestimate the prevalence of 
hypertension because it does not include people not aware of being 
suffering from hypertension. Moreover, according to more recent 
guide-lines (45) we used cut-off point for hypertension lower than 
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those used in previous studies (40, 41, 42). According to gender, men 
are affected by hypertension more than women (42,43). The 
distribution of hypertension prevalence in the five examined 
macroareas is different comparing our study with previous ones (40, 
42), except for the lowest prevalence in Islands (40) and the highest 
prevalence in North-east (42). 
The trend of smoking prevalence seems to be reduced comparing our 
data (19%) with both OEC (25.5%) and ISTAT ones (23.9%; 21.7%), 
even if in these studies the age of the examined populations are not 
strictly overlapped (40, 41, 42). Differences could also be ascribed to 
the different period of screening; in fact, the trend of people who quit 
smoking has increased over the last few years (41) and this could be 
maybe due to huge national prevention programs and also to the 
introduction of the Italian anti-smoking legislation in January 2005, 
banning smoking in public places. Moreover, according to previous 
studies men smoke more than women (40, 41, 42), with an almost 
doubled prevalence in South macroarea; and South and Islands show 
the highest prevalence of smokers (42). 
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Over the last 50 years, many studies have evaluated the associations 
between food groups and chronic diseases, and a consensus about the 
role of nutritional factors in the aetiology of these diseases has 
gradually emerged (70, 71, 72). In particular, data from 
epidemiological studies showed that increased consumption of fruit 
and vegetables can reduce the overall mortality in both healthy 
subjects and patients (73). Actually, nutritional recommendations for 
fruit&vegetables have been recently reviewed and have been raised 
from the five servings-a-day to the more ambitious seven (or nine) 
servings-a-day (51). Unfortunately, the average daily intake of fruit 
and vegetables has not simultaneously increased over the last years. In 
fact, even by considering the recommended range between 3 and 5 
servings-a-day according to the major scientific associations (48, 49, 
50, 51), only 66% of the study population reach the optimal intake for 
fruit and vegetables, and many subjects are far from reaching the 
optimal intake for these foods (69). It is interesting that in North-west, 
North-east and Center population the prevalence of people showing a 
fruit and vegetable consumption in the recommended range is higher 
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than South and Islands population. A possible explanation for this 
finding could be related to a low household income (74).  
No recent surveys have examined wine intake according to the range 
that we consider as recommended in our study (52). The prevalence of 
people who has declared a wine intake in the recommended range 
(77%) could be considered acceptable. According to ISTAT (40), the 
prevalence of people showing a higher alcohol consumption than 
recommended is almost doubled in North-west, North-east and Center 
population compared to South and Islands population. 
As the risk factors are individually important, having more than one 
risk factor tend to magnify the risk of chronic disease (75). 
Our study shows that 89 % of the study population has more than one 
CRF for CVD and we think that these results are alarming. Moreover, 
as hypertension (73%), obesity/overweigh (63%), diabetes (15%) and 
dyslipidaemia (hypertriglyceridemia 42% and hypercholesterolemia 
36%) occur frequently in the study population, it is not surprising that 
an individual might manifest two or more of these disorders. In 
agreement with data from a study of Caucasian populations (76) our 
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study finds an overlapping pattern of CRFs in the Italian population, 
and much more than half of the study population has between two and 
five risk factors (72%), with 17% of the examined population having 
six or more risk factors (figure 1). 
Since in our study obesity/overweight and high waist circumference 
are both independently associated with the same CVRFs 
(hypertension, hypertriglyceridemia and diabetes) in a multiple logistic 
regression model (Table 5 and 6), both obesity/overweight and high 
waist circumference represent a serious health concern. Therefore it 
should be very important to inform people about the possible 
association between obesity per se and/or high waist circumference 
and other CRFs. Moreover, BMI and waist circumference may be a 
good choice in clinical practice and could be useful to alert people.  
Interestingly, the highest prevalence of family history of both 
hypertension (53%) and dislypidemia (30%) is find in North-west 
population according to the highest prevalence of hypertension (76%) 
and hypercholesterolemia (39%) in this macroarea. In addition, the 
lowest prevalence of both obesity (16%) and diabetes (12%) such as of 
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family history of both obesity (16%) and diabetes (30%) are found in 
North-east, and the lowest prevalence hypertension (67%) and of 
family history of  hypertension (42%) is shown by Islands population. 
Moreover, the highest prevalence of a positive family history of all the 
examined CRFs is found in women; this could be maybe explained by 
the cultural habits and psychological inclination of women taking more 
care of parents‘ health than men. 
In conclusion, the strength of our study is that we have analyzed 
several, classical and new, CRFs in a large sample of the Italian 
population using direct measurements. Our data reveal alarming results 
on the prevalence of some CRFs, highlighting the need of several 
approaches to identify individuals at risk by using simple 
anthropometric parameters and clinical markers as screening tools. 
Moreover, our findings also emphasize the importance to plan early 
and urgent appropriate intervention programs aimed at modifying 
lifestyle and eating habits in the Italian population and aimed at 
preventing CVDs. In particular it could be very important to plan 
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intervention programs taking into account the differences among 
macroareas in the prevalence of CRFs. 
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Table 1. Main demographic, clinical and metabolic characteristics of the study population by gender and macroarea 
 
 
Data are expressed as n. or mean ± SD as appropriate 
 Study population North-west 
 
North-east 
 
Center 
 
South 
 
Islands 
 
 
 
n. 
M 
 
12626 
F 
 
11587 
Tot 
 
24609 
M 
 
1585 
F 
 
1892 
Tot 
 
3477 
M 
 
1692 
F 
 
2101 
Tot 
 
3793 
M 
 
3032 
F 
 
3114 
Tot 
 
6146 
M 
 
4650 
F 
 
3438 
Tot 
 
8088 
M 
 
1667 
F 
 
1042 
Tot 
 
2709 
Age  
(years)  
 
 
58±15 
 
55±15 
 
57±15 
 
59±14 
 
58±14 
 
58±14 
 
58±15 
 
57±15 
 
58±15 
 
59±15 
 
56±15 
 
57±15 
 
58±15 
 
53±16 
 
56±16 
 
57±15 
 
52±16 
 
55±16 
Weight  
(Kg)  
 
 
80±12 
 
66±12 
 
73±14 
 
80±12 
 
65±12 
 
72±14 
 
81±12 
 
66±12 
 
73±14 
 
80±12 
 
66±12 
 
73±14 
 
79±13 
 
68±13 
 
74±14 
 
78±12 
 
65±11 
 
73±13 
BMI  
(Kg/m2)  
 
 
27.5±3.9 
 
26.2±4.9 
 
26.9±4.4 
 
27.0±3.9 
 
25.5±4.7 
 
26.2±4.4 
 
26.8±3.7 
 
25.3±4.3 
 
26.0±4.1 
 
27.3±3.7 
 
26.1±4.7 
 
26.7±4.3 
 
28.0±3.9 
 
27.1±5.1 
 
27.6±4.5 
 
27.5±3.8 
 
26.0±4.6 
 
26.9±4.2 
Waist Circumference 
 (cm) 
 
 
101±11 
 
91±13 
 
97±13 
 
100±11 
 
90±13 
 
95±13 
 
100±11 
 
90±12 
 
95±13 
 
100±10 
 
91±13 
 
96±12 
 
103±12 
 
94±15 
 
99±14 
 
102±12 
 
89±13 
 
97±14 
Systolic blood pressure 
(mmHg) 
 
 
136±18 
 
132±19 
 
134±19 
 
139±18 
 
135±20 
 
137±19 
 
139±19 
 
134±19 
 
136±19 
 
137±18 
 
132±19 
 
135±19 
 
136±18 
 
131±20 
 
134±19 
 
131±16 
 
126±17 
 
129±16 
Diastolic blood pressure 
(mmHg) 
 
 
81±11 
 
79±11 
 
80±11 
 
82±10 
 
80±10 
 
81±10 
 
81±11 
 
80±11 
 
80±11 
 
81±11 
 
79±11 
 
80±11 
 
81±11 
 
79±11 
 
80±11 
 
79±10 
 
77±10 
 
78±10 
Total Cholesterol 
(mg/dl) 
 
 
182±33 
 
190±35 
 
186±34 
 
184±29 
 
192±32 
 
188±31 
 
181±34 
 
190±35 
 
186±35 
 
182±36 
 
191±37 
 
187±36 
 
183±32 
 
189±34 
 
185±33 
 
180±31 
 
190±39 
 
184±34 
Triglycerides 
(mg/dl)  
 
 
149±78 
 
158±84 
 
153±81 
 
144±75 
 
164±85 
 
155±81 
 
159±86 
 
169±90 
 
164±88 
 
150±78 
 
162±86 
 
156±83 
 
150±77 
 
150±79 
 
150±78 
 
143±71 
 
146±74 
 
144±72 
Blood Glucose  
(mg/dl) 
 
 
86±37 
 
81±30 
 
83±34 
 
87±35 
 
80±27 
 
83±31 
 
83±29 
 
79±25 
 
81±27 
 
88±33 
 
85±31 
 
87±32 
 
79±33 
 
84±39 
 
82±37 
 
78±31 
 
86±43 
 
83±39 
  
 
 
 
Table 2. Prevalence of some cardiovascular risk factors in the study population by gender and macroarea 
 
 
 
 Study 
population 
North-west 
 
North-east 
 
Center 
 
South 
 
Islands 
 
 M F Tot M F Tot M F Tot M F Tot M F Tot M F Tot 
Obesity 
% 
23 20 22 19 17 18 17 14 16 21 19 20 28 26 27 23 19 21 
Overweight 
% 
51 34 41 50 32 40 51 36 43 52 35 43 48 36 43 51 34 44 
High Waist Circumference 
% 
51 62 56 48 58 53 47 57 52 48 64 55 54 67 59 55 59 56 
Smoking 
% 
22 15 19 17 13 15 18 15 17 21 18 19 25 13 20 27 20 24 
Hypertension 
% 
78 67 74 82 71 76 81 72 76 79 66 73 78 65 72 72 59 67 
Hypertriglyceridemia 
% 
40 45 42 38 49 44 43 47 45 42 48 45 39 40 40 36 38 37 
Hypercholesterolemia 
% 
30 42 36 32 45 39 31 44 38 31 42 37 30 39 34 29 42 34 
Diabetes 
% 
17 12 15 16 13 14 14 11 12 15 11 13 19 14 17 18 12 16 
Hyperglycemia 
% 
14 12 13 15 12 13 13 9 11 19 17 18 11 10 10 11 8 10 
 
  
 
 
 
 
 
 
Table 3. Prevalence of fruits&vegetables and alcohol consumption in the study population by gender and macroarea 
 
 
 
 Study 
population 
North-west 
 
North-east 
 
Center 
 
South 
 
Islands 
 
 M F Tot M F Tot M F Tot M F Tot M F Tot M F Tot 
Fruit&Vegetables° 
(%) 
63 70 66 72 77 75 74 81 78 68 75 72 55 56 56 57 65 60 
Alcohol* 
(%) 
23 23 23 32 29 30 28 28 28 25 25 25 20 17 18 16 16 16 
 
 
° Fruits&Vegetables consumption between the recommended range (3 - 5 servings/day)  
 
* Alcohol considered as wine consumption higher than recommended intake (>1 glass for men, >½ glass for women)  
  
 
 
 
 
 
Table 4. Family history of some cardiovascular risk factors in the study population by gender and macroarea 
 
 
 
 Study 
population 
North-west 
 
North-east 
 
Center 
 
South 
 
Islands 
 
 M F Tot M F Tot M F Tot M F Tot M F Tot M F Tot 
Family history of  
Obesity (%) 
15 21 17 16 22 19 14 18 16 15 21 18 16 21 18 14 20 16 
Family history of 
Hypertension (%) 
38 54 45 44 60 53 35 48 42 41 54 47 37 56 45 36 52 42 
Family history of 
Dislypidemia (%) 
22 31 26 24 34 30 19 25 22 25 34 29 19 30 24 22 35 27 
Family history of  
Diabetes (%) 
31 37 33 32 38 35 28 32 30 31 36 33 31 37 33 33 42 37 
 
  
 
Table 5. Association with obesity/overweight (yes vs no) of the considered cardiovascular risk 
factors in a multivariate analysis, adjusted for high waist circumference, gender, macroarea, 
fruit&vegetables and alcohol intake. 
  OR p C.I. 95% 
Age ( years)  0.991 0.001 0.988-0.994 
Smoking (yes vs no)  0.831 0.001 0.753-0.918 
Diabetes (yes vs no)  1.320 0.001 1.219-1.429 
Hypertension (yes vs no)  1.790 0.001 1.619-1.978 
Hypercholesterolemia (yes vs no)  0.921 0.041 0.852-0.996 
Hypertriglyceridemia (yes vs no)  1.167 0.001 1.082-1.259 
 
 
 
 
 
  
 
 
Table 6. Association with high waist circumference (yes vs no) of the considered cardiovascular risk factors in a 
multivariate analysis, adjusted for obesity/overweight, gender, macroarea, fruit&vegetables and alcohol intake. 
  OR p C.I. 95% 
Age ( years)  1.028 0.001 1.026-1.030 
Smoking (yes vs no)  0.937 0.108 0.865-1.014 
Diabetes (yes vs no)  1.345 0.001 1.251-1.452 
Hypertension (yes vs no)  1.615 0.001 1.499-1.740 
Hypercholesterolemia (yes vs no)  0.955 0.178 0.893-1.021 
Hypertriglyceridemia (yes vs no)  1.324 0.001 1.240-1.413 
 
 
  
 
  
 
 
 
 
Figure 1. Distribution of the cardiovascular risk factors in the study population according to gender 
 
0
5
10
15
20
25
0 1 2 3 4 5 6 7 8 9 10
N. of cardiovascular risk factors
P
r
e
v
a
le
n
c
e
 (
%
)
TOTALE
MAS CHI
F E MMINE
